The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Binosto Once Weekly 70 mg effervescent tablets

Clonmel Healthcare LtdPA0126/280/001

Main Information

Trade NameBinosto Once Weekly 70 mg effervescent tablets
Active SubstancesAlendronic acid
Dosage FormEffervescent tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/280/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA04 alendronic acid


License statusAuthorised
Licence Issued02/03/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back